Citadel Advisors
CSCI

Citadel Advisors’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Citadel Advisors’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-86
Closed -$640 – 15585
2023
Q4 		$640 Buy
+86
New +$635 ﹤0.01% 13979
2022
Q3 		– Sell
-600
Closed -$12K – 13777
2022
Q2 		$12K Buy
600
+36
+6% +$901 ﹤0.01% 12551
2022
Q1 		$21K Sell
564
-218
-28% -$7.84K ﹤0.01% 13229
2021
Q4 		$28K Sell
782
-411
-34% -$21.6K ﹤0.01% 13499
2021
Q3 		$89K Sell
1,193
-339
-22% -$24.1K ﹤0.01% 12987
2021
Q2 		$134K Buy
1,532
+189
+14% +$18K ﹤0.01% 12629
2021
Q1 		$153K Buy
+1,343
New +$149K ﹤0.01% 12008
2020
Q3 		– Sell
-229
Closed -$18K – 10861
2020
Q2 		$18K Buy
+229
New +$21K ﹤0.01% 9571
2020
Q1 		– Sell
-144
Closed -$13K – 10305
2019
Q4 		$13K Sell
144
-20
-12% -$1.86K ﹤0.01% 8990
2019
Q3 		$17K Sell
164
-14
-8% -$3.03K ﹤0.01% 8978
2019
Q2 		$53K Buy
178
+78
+78% +$27.5K ﹤0.01% 8717
2019
Q1 		$47K Buy
+100
New +$38.8K ﹤0.01% 8843
2018
Q3 		– Sell
-105
Closed -$20K – 9783
2018
Q2 		$20K Buy
105
+2
+2% +$369 ﹤0.01% 8653
2018
Q1 		$15K Sell
103
-65
-39% -$12.7K ﹤0.01% 8156
2017
Q4 		$40K Sell
168
-13
-7% -$2.71K ﹤0.01% 7693
2017
Q3 		$37K Buy
+181
New +$33.3K ﹤0.01% 7250
2017
Q2 		– Sell
-211
Closed -$63K – 8183
2017
Q1 		$63K Buy
+211
New +$62.1K ﹤0.01% 6993

Other funds holding CSCI

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Citadel Advisors's CSCI Position: Q2 2024 in Review

Citadel Advisors sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q2 2024, closing a stake of 3,960 shares — an estimated $33.9K sold.

Citadel Advisors first reported a position in CSCI in Q4 2014 and held it in 16 quarters. The position peaked at $133K in Q1 2019. 13 funds tracked by Wall St. Rank hold CSCI as of Q2 2024.

  • Citadel Advisors reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 3,960 COSCIENS Biopharma Inc. Common Stock shares in Q2 2024, an estimated $33.9K.
  • Citadel Advisors first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2014 and held it in 16 quarters.
  • Citadel Advisors's COSCIENS Biopharma Inc. Common Stock position peaked at $133K in Q1 2019.
  • 13 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.